Abstract:The last decade has witnessed the growing development of optical imaging using near-infrared (NIR) light (wavelength range: 700–1700 nm) in a wide range of applications, from fundamental research of live biological and physiological processes to clinical applications such as disease screening and image-guide surgical interventions. The low-energy NIR light offers reduced tissue scattering, absorption as well as autofluorescence background compared to traditional wavelengths in the visible (400–700 nm) range, thus dramatically enhancing imaging resolution, signal-to-noise ratio, and penetration depth. This Research Topic calls for advances in new fluorescent probes, imaging instrumentation, analytical methods and their applications for improvement of diagnosis and therapy in this “tissue transparent window,” aiming to provide a timely update of this continuously evolving filed. Imaging and diagnosis agents are the cornerstone of preclinical applications. In their study, Tan et al. report lycosin-I peptide modified gold nanoclusters (LGNCs), which exhibit strong NIR fluorescence, for imaging of specific cancer cell nuclei. The lycosin-I peptide not only possesses highly efficient and selective intracellular translocation against several cancer cells, but also induces aggregation of gold nanoclusters to further enhance their brightness. After uptake by tumor cells, the LGNCs aggregates can be depolymerized into ultrasmall nanoclusters by the high level GSH in the tumor microenvironment, facilitating nuclear targeting translocation in cancer cells. Another study by Huang et al. reports a novel biomimetic nanoprobe for photoacoustic (PA) imaging of cervical carcinoma. This probe is constructed by coating indocyanine green (ICG)-loaded mesoporous silica nanoparticles with the cancer cell membrane, providing small particle size, excellent dispersion, large loading efficiency, good biocompatibility and homologous targeting ability to Hela cells in vitro. The biomimetic nanoprobe can specifically accumulate into tumor and display a superior PA imaging efficacy compared with free ICG, allowing for non-invasive deep tissue imaging of cervical carcinoma in vivo. Another article by Gu et al. focuses on a particular type of NIR fluorophores, semiconducting polymer nanoparticles (SPNs). SPNs are constructed by encapsulating hydrophobic semiconducting polymers (SPs) with amphiphilic copolymers, and have shown great promise for phototheranostics of cancer. The authors review recent advances of thiadiazoloquinoxaline (TQ)-based SPNs from their synthesis and hydrophilic functionalization to NIR-II (1,000–1,700 nm) fluorescence imagingguided cancer photothermal therapy (PTT). To enhance the PTT efficiency, they also discuss methods for constructing SPNs with capability of multimodal imaging. Current limitations are summarized at the end that hamper clinical applications of the SPNs, such as relatively large size and low tumor targeting ability. Edited and reviewed by: Gianni Ciofani, Italian Institute of Technology (IIT), Italy

Review of NIR-responsive ''Smart'' Carriers for Photothermal Chemotherapy

Indocyanine-type Infrared-820 Encapsulated Polymeric Nanoparticle-Assisted Photothermal Therapy of Cancer

Near-infrared light-activatable polymeric nanoformulations for combined therapy and imaging of cancer

Tumor-microenvironment activated second near-infrared agents for tumor imaging and therapy

Cancer Theranostics with Near-Infrared Light-Activatable Multimodal Nanoparticles.

Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy

Near-infrared photoresponsive drug delivery nanosystems for cancer photo-chemotherapy

Near-infrared light activated delivery platform for cancer therapy

Recent Near-Infrared Light-Activated Nanomedicine Toward Precision Cancer Therapy

Near-infrared-responsive Functional Nanomaterials: the First Domino of Combined Tumor Therapy

Facile Fabrication Of A Near-Infrared Responsive Nanocarrier For Spatiotemporally Controlled Chemo-Photothermal Synergistic Cancer Therapy

Carrier‐Free Biomimetic Organic Nanoparticles with Super‐High Drug Loading for Targeted NIR‐II Excitable Triple‐Modal Bioimaging and Phototheranostics

NIR‐II Responsive Inorganic 2D Nanomaterials for Cancer Photothermal Therapy: Recent Advances and Future Challenges

Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies.

Recent Progress on NIR-II Photothermal Therapy

Applications of Nanotheranostic in the Second Near-Infrared Window in Bioimaging and Cancer Treatment

Near‐Infrared‐II Nanomaterials for Activatable Photodiagnosis and Phototherapy

Editorial: Precise Diagnosis and Therapy Using Near-Infrared Light

Recent advances in near-infrared-II hollow nanoplatforms for photothermal-based cancer treatment

Advances in biodegradable nanomaterials for photothermal therapy of cancer

Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment